Related Experiment Video
Updated: Sep 9, 2026

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells
Published on: April 4, 2016
Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family
W Van Hul1, W Wuyts, J Hendrickx
1Department of Medical Genetics, University of Antwerp, Belgium. vhul@uia.ua.ac.be
Abstract:
Two homologous genes, EXT1 and EXT2, responsible for the development of benign multiple cartilagenous bone tumors (exostoses) on the long bones, have been identified in the past 2 years. Several arguments have been provided to support the hypothesis that these genes have tumor suppressor activity and that loss of function of these genes may contribute to the development of bone tumors. The recent identification of two EXT-like genes, EXTL1 and EXTL2, homologous to the EXT genes and to each other, revealed the existence of a larger family of genes. We now report the identification of a homologous EST (EST01365), not derived from the known EXT and EXTL genes, indicating the existence of one additional member of this gene family. We characterized this third EXT-like gene, EXTL3, and compared it with the other four members of the EXT-EXTL family. In view of its putative tumor suppressor function, the EXTL3 gene can be considered a candidate gene for the breast cancer locus on chromosome 8p12-p22.
Insights
Researchers identified a new gene, EXTL3, expanding the EXT-EXTL gene family. This gene may function as a tumor suppressor and is a candidate for breast cancer research.
Area of Science:
- Genetics
- Oncology
Background:
- Two homologous genes, EXT1 and EXT2, are linked to benign multiple cartilaginous bone tumors (exostoses).
- These genes are hypothesized to possess tumor suppressor activity, with loss of function potentially causing bone tumors.
- The discovery of EXT-like genes (EXTL1, EXTL2) indicated a larger gene family.
Purpose of the Study:
- To identify and characterize additional members of the EXT-EXTL gene family.
- To investigate the potential role of the newly identified gene, EXTL3, in tumor suppression.
- To evaluate EXTL3 as a candidate gene for breast cancer on chromosome 8p12-p22.
Main Methods:
- Homologous expressed sequence tag (EST) screening to identify novel genes.
- Gene characterization and comparison with known EXT-EXTL family members.
- Analysis of EXTL3's potential tumor suppressor function.
Main Results:
- Identification of a novel homologous EST (EST01365), representing a new gene member, EXTL3.
- Characterization of EXTL3 and comparison with EXT1, EXT2, EXTL1, and EXTL2.
- EXTL3 exhibits characteristics suggesting a tumor suppressor role.
Conclusions:
- The EXT-EXTL gene family comprises at least five members, including the newly identified EXTL3.
- EXTL3 is a strong candidate gene for the breast cancer locus on chromosome 8p12-p22 due to its putative tumor suppressor function.
More Related Videos
Related Concept Videos
Pleiotropy
Inheritance of Chromatin Structures
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Non-LTR Retrotransposons
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Reporter Genes
Commonly used reporter...

